Wai Conrad 4
Research Summary
AI-generated summary
Clover Health CEO Wai Conrad Sells 24,215 Shares
What Happened Wai Conrad, CEO of Clover Health Investments (CLOV) and co-trustee of a family trust, sold 24,215 shares on 2026-07-15 at a weighted-average price of $4.67, generating approximately $113,084. The shares were disposed (sale) and the filing was submitted on 2026-07-16.
Key Details
- Transaction type: Sale (code S); proceeds ≈ $113,084.
- Date of transaction: 2026-07-15; Form filed: 2026-07-16 (appears timely).
- Price: weighted average $4.67; individual trades ranged $4.67–$4.73 (footnote F2).
- Reason: Sell-to-cover to satisfy tax withholding on the vesting of 6.25% of RSUs originally granted 10/15/2024 (footnote F1). These sales were mandated by the issuer’s equity plan and are not discretionary trades.
- Other note: Some shares are held in trust for the Reporting Person’s family, of which the Reporting Person is a co-trustee (footnote F3).
- Shares owned after the transaction: not specified in the provided excerpt.
Context This was a routine sell-to-cover tied to RSU vesting (tax withholding), which is common and does not necessarily indicate a change in insider sentiment. Sales required by equity-plan withholding are treated differently from voluntary open-market disposals.